251 related articles for article (PubMed ID: 26414153)
1. Cellular signaling pathways implicated in metastasis of colorectal cancer and the associated targeted agents.
Liu X; Ji Q; Fan Z; Li Q
Future Oncol; 2015; 11(21):2911-22. PubMed ID: 26414153
[TBL] [Abstract][Full Text] [Related]
2. Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements.
Malki A; ElRuz RA; Gupta I; Allouch A; Vranic S; Al Moustafa AE
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374459
[TBL] [Abstract][Full Text] [Related]
3. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
4. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
[TBL] [Abstract][Full Text] [Related]
5. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
6. Anti-metastatic treatment in colorectal cancer: targeting signaling pathways.
Lemos C; Sack U; Schmid F; Juneja M; Stein U
Curr Pharm Des; 2013; 19(5):841-63. PubMed ID: 22973955
[TBL] [Abstract][Full Text] [Related]
7. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
Song L; Li Y; He B; Gong Y
Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
[TBL] [Abstract][Full Text] [Related]
8. P53 mutations in colorectal cancer - molecular pathogenesis and pharmacological reactivation.
Li XL; Zhou J; Chen ZR; Chng WJ
World J Gastroenterol; 2015 Jan; 21(1):84-93. PubMed ID: 25574081
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal transition in colorectal cancer metastasis: A system review.
Cao H; Xu E; Liu H; Wan L; Lai M
Pathol Res Pract; 2015 Aug; 211(8):557-69. PubMed ID: 26092594
[TBL] [Abstract][Full Text] [Related]
10. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
[TBL] [Abstract][Full Text] [Related]
11. The Notch pathway in colorectal cancer.
Vinson KE; George DC; Fender AW; Bertrand FE; Sigounas G
Int J Cancer; 2016 Apr; 138(8):1835-42. PubMed ID: 26264352
[TBL] [Abstract][Full Text] [Related]
12. Novel drug discovery opportunities for colorectal cancer.
Curtin JC
Expert Opin Drug Discov; 2013 Sep; 8(9):1153-64. PubMed ID: 23768167
[TBL] [Abstract][Full Text] [Related]
13. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model.
Kunnumakkara AB; Diagaradjane P; Anand P; Harikumar KB; Deorukhkar A; Gelovani J; Guha S; Krishnan S; Aggarwal BB
Int J Cancer; 2009 Nov; 125(9):2187-97. PubMed ID: 19623659
[TBL] [Abstract][Full Text] [Related]
14. Targeting key transcriptional factor STAT3 in colorectal cancer.
Chalikonda G; Lee H; Sheik A; Huh YS
Mol Cell Biochem; 2021 Sep; 476(9):3219-3228. PubMed ID: 33866491
[TBL] [Abstract][Full Text] [Related]
15. LGR5 regulates survival through mitochondria-mediated apoptosis and by targeting the Wnt/β-catenin signaling pathway in colorectal cancer cells.
Hsu HC; Liu YS; Tseng KC; Tan BC; Chen SJ; Chen HC
Cell Signal; 2014 Nov; 26(11):2333-42. PubMed ID: 25025569
[TBL] [Abstract][Full Text] [Related]
16. NF-κB pathways in the development and progression of colorectal cancer.
Patel M; Horgan PG; McMillan DC; Edwards J
Transl Res; 2018 Jul; 197():43-56. PubMed ID: 29550444
[TBL] [Abstract][Full Text] [Related]
17. SATB1 and colorectal cancer in Wnt/β-catenin signaling: Is there a functional link?
Meng WJ; Yan H; Li Y; Zhou ZG
Med Hypotheses; 2011 Feb; 76(2):277-9. PubMed ID: 21122998
[TBL] [Abstract][Full Text] [Related]
18. Specificity protein 1: Its role in colorectal cancer progression and metastasis.
Bajpai R; Nagaraju GP
Crit Rev Oncol Hematol; 2017 May; 113():1-7. PubMed ID: 28427500
[TBL] [Abstract][Full Text] [Related]
19. The SOX17/miR-371-5p/SOX2 axis inhibits EMT, stem cell properties and metastasis in colorectal cancer.
Li Y; Lv Z; He G; Wang J; Zhang X; Lu G; Ren X; Wang F; Zhu X; Ding Y; Liao W; Ding Y; Liang L
Oncotarget; 2015 Apr; 6(11):9099-112. PubMed ID: 25868860
[TBL] [Abstract][Full Text] [Related]
20. Targeted Treatment against Cancer Stem Cells in Colorectal Cancer.
Martínez-Pérez J; Torrado C; Domínguez-Cejudo MA; Valladares-Ayerbes M
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
